% Expired Patents = 40.0

Forward Citations = 154

Loading Chart...

5 inventors (with patents filed for the assignee):

Michael D Weil (3 out of 5 patents)

Kevin N Morris (2 out of 2 patents)

Webster Cash (2 out of 3 patents)

4. Rainer M Malzbender (1 out of 10 patents)

5. Webster C Cash, Jr (1 out of 6 patents)

5 patents: Sort by Forward Citations

1. 8709380 - Targeting agents for enhancing radiation therapy (2014-04-29),

2. 7481758 - Pharmaceutically enhanced low-energy radiosurgery (2009-01-27),

3. 6560312 - Medical uses of focused and imaged X-rays (2003-05-06),

4. 6366801 - Pharmaceutically enhanced low-energy radiosurgery (2002-04-02),

5. 6359963 - Medical uses of focused and imaged x-rays (2002-03-19),

Company Overview

Sirius Medicine, LLC is a biopharmaceutical company focused on developing innovative therapeutics for serious and life-threatening diseases. With a team of experienced researchers and scientists, we are dedicated to advancing groundbreaking treatments that have the potential to improve the lives of patients worldwide. Our mission is to bring hope and healing to those in need through the power of science and medicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#52 in Fort Collins, CO

#1,156 in Colorado

#51,620 in US

Fort Collins, CO, United States of America

Sirius Medicine, LLC

Forward Citations = 154

5 inventors:

Michael D Weil (3 out of 5 patents)

Kevin N Morris (2 out of 2 patents)

Webster Cash (2 out of 3 patents)

4. Rainer M Malzbender (1 out of 10 patents)

5. Webster C Cash, Jr (1 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sirius Medicine, LLC. Retrieved from https://idiyas.com/company/sirius-medicine

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]